Letters to the Editor

Letters to the Editor are no longer included in the main BJUI journal, but we will continue to publish them on the BJUI website as an important part of the scientific debate.

Letters Policy

  • Letters to the editor will now published in electronic form on the journal website (www.bjuinternational.com), not in the journal itself. As such, letters are not submitted to PubMed for indexing.
  • Letters to the editor should be 500 words or less, preference is given to concise letters.
  • Writers are limited to one letter published on the website per month.
  • Letters must include full author contact details.
  • All letters will be peer-reviewed, and we reserve the right to reject letters, or to edit them if they are accepted.
  • If accepted, letters are sent to the authors of the paper being discussed, to give them the chance to make a response that will (if accepted) be published at the same time as the letter.
  • Letters will not be open for public comment; replies must be submitted by email to the Editorial Office for review.

Re: Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

/
Letter to the Editor Dear Sir Fluoroquinolones must not be used inappropriately when treating chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS). Clinical guidelines from the Prostatitis Expert Reference Group (PERG) on chronic bacterial prostatitis (CBP), chronic prostatitis and chronic pelvic pain syndrome [1] — which have been propagated by other guideline providers such as NICE Clinical Knowledge Summaries and the primary care resource, Guidelines — include the following…

Re. Recommended antibiotic prophylaxis regimen in retrograde intrarenal surgery: evidence from a randomised controlled trial.

/
Letter to the Editor Recommended antibiotic prophylaxis regimen in retrograde intrarenal surgery: evidence from a randomised controlled trial. Dear Sir, Zhao et al. emphasized that antibiotic prophylaxis for < 200 mm2 stones was not required in patients with sterile preoperative urine culture according to a single-center controlled randomized clinical design. The decision of antibiotic prophylaxis before urological interventions is still determined by the deterioration of urinary…

Re. Genetic correlates of prostate cancer visibility (and invisibility) on mpMRI: It’s time to take stock.

/
Letter to the Editor Genetic correlates of prostate cancer visibility (and invisibility) on mpMRI: It's time to take stock. Dear Sir, In their paper on multiparametric magnetic resonance imaging [1], Norris et  al. argue that because “men with overall Gleason score 3 + 4 [do] not suffer prostate cancer-related death” and “men with overall Gleason score 4 + 3 [do not have] negative pre-biopsy mpMRI” therefore “mpMRI may identify all truly significant cancer”. This may be behind…

Re: Suture Techniques during Laparoscopic and Robot-Assisted Partial Nephrectomy

Letter to the Editor Suture Techniques during Laparoscopic and Robot-Assisted Partial Nephrectomy: A Systematic Review and Quantitative Synthesis of Peri-Operative Outcomes Dear Sir, We would like to congratulate the authors of this systematic review [1] highlighting the evolution of suture techniques for partial nephrectomy in the era of minimally invasive surgery. The authors note the “significant technical modification” for the replacement of intracorporeal free-hand knot tying with…

Re: Incidentally detected testicular lesions <10 mm in diameter: can orchidectomy be avoided?

Letter to the Editor Incidentally detected testicular lesions <10 mm in diameter: can orchidectomy be avoided? Dear Sir, We have read with great interest the paper “Incidentally detected testicular lesions <10 mm in diameter: can orchidectomy be avoided?” by Scandura et al. (1) in which only one third of such lesions turned out to be malignant and 100% of those <5 mm were benign. The authors call those patients who underwent orchidectomy for benign lesions “victims of modern…
© 2020 BJU International. All Rights Reserved.